4.5 Article

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 83, 期 1, 页码 89-101

出版社

IOS PRESS
DOI: 10.3233/JAD-210105

关键词

Agitation; behavioral symptoms; cognitive dysfunction; cost of illness; cross-sectional studies; dementia; health care costs; institutionalization; real-world; referral and consultation; therapeutics

资金

  1. Otsuka Pharmaceutical Development & Commercialization, Inc.
  2. Lundbeck, LLC
  3. Good Publication Practice guidelines
  4. Lundbeck LLS

向作者/读者索取更多资源

This study aimed to assess the impact of agitation in patients with dementia on healthcare resource utilization and healthcare costs. The results showed that agitation was associated with patients having professional caregivers, being institutionalized, receiving antipsychotic/antidepressant medications, number of consultations with healthcare professionals, hospitalizations, and healthcare costs.
Background: At least 90%of patients with dementia experience behavioral or neuropsychiatric symptoms including agitation, psychotic symptoms, apathy, depression, and sleep disturbances. Agitation has been reported to be experienced by 60%of patients with mild cognitive impairment and 76%of patients with Alzheimer's disease. Objective: We aimed to assess the impact of agitation in patients with dementia on healthcare resource utilization (HCRU) and healthcare costs. Methods: This was a retrospective analysis of physician-reported patient data from a point-in-time survey. Patients included were aged >= 50 years, with early cognitive impairment or dementia. Agitated and non-agitated patients were compared. Regression analyses assessed the relationship of agitation score (calculated from number/severity of agitation symptoms) with outcomes, with covariates including age and Mini-Mental State Examination score. Sensitivity analyses compared patients with 0 and >= 2 agitation symptoms following propensity score matching on the base-case covariates. Results: Data were included for 1,349 patients (agitated, n = 693; non-agitated, n = 656). Based on regression analyses, agitation score was correlated with proportion of patients with professional caregivers (p < 0.01), institutionalized (p < 0.01), hospitalized in a psychiatric ward (p < 0.05), and receiving an antipsychotic/antidepressant (both p < 0.001); number of consultations with a healthcare professional (HCP), psychiatrist, or psycho-geriatrician; number and cost of hospitalizations (p < 0.01); cost of HCP consultations (p < 0.001); and total direct healthcare costs (p < 0.001). Sensitivity analyses generally supported the base-case analysis. Conclusion: Agitation in dementia is associated with increased HCRU and healthcare costs. Effective therapies are needed to address agitation in dementia, with the potential to alleviate patient impact, HCRU, and healthcare costs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据